Csl Ltd ADR (CSLLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | CSLLY | VRTX | REGN | ||
Company | Csl Ltd ADR | Vertex Pharmaceutic | Regeneron Pharmaceuticals | ||
Price Information | |||||
Exchange | OTC US | NASDAQ | NASDAQ | ||
Open | 86.0200 | 401.53 | 712.30 | ||
High | 90.0300 | 410.68 | 720.00 | ||
Low | 86.0200 | 401.27 | 706.15 | ||
Last | 88.7500 | 408.18 | 714.47 | ||
Change | +0.9600 | +2.91 | -0.66 | ||
% Change | +1.09% | +0.72% | -0.09% | ||
Volume | 90,500 | 1,468,500 | 382,100 | ||
20-Day Average Volume | 64,250 | 1,832,675 | 872,050 | ||
Previous Close | 87.7900 | 405.27 | 715.13 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 89.2858 | 452.00 | 745.06 | ||
20-Day Raw Stochastic | 46.62% | 30.76% | 19.88% | ||
20-Day Relative Strength | 43.02% | 33.99% | 31.85% | ||
Weighted Alpha | -10.92 | -7.89 | -29.75 | ||
Today's Opinion | 88% Sell | 72% Sell | 100% Sell | ||
Previous Opinion | 88% Sell | 72% Sell | 100% Sell | ||
Last Month's Opinion | 72% Sell | 24% Sell | 88% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | +0.37% since 12/17/24 | -13.01% since 12/17/24 | -3.45% since 12/17/24 | ||
Low | 83.3100 on 12/20/24 | 377.85 on 12/19/24 | 693.00 on 12/19/24 | ||
High | 90.0300 on 12/24/24 | 471.05 on 12/18/24 | 745.00 on 12/18/24 | ||
1-Month | |||||
%Chg | -1.39% since 11/22/24 | -9.49% since 11/22/24 | -3.19% since 11/22/24 | ||
Low | 83.3100 on 12/20/24 | 377.85 on 12/19/24 | 693.00 on 12/19/24 | ||
High | 94.9800 on 11/26/24 | 476.46 on 12/10/24 | 800.99 on 12/09/24 | ||
3-Month | |||||
%Chg | -10.74% since 09/24/24 | -11.84% since 09/24/24 | -31.69% since 09/24/24 | ||
Low | 83.3100 on 12/20/24 | 377.85 on 12/19/24 | 693.00 on 12/19/24 | ||
High | 101.4400 on 10/21/24 | 519.88 on 11/08/24 | 1,070.00 on 09/27/24 | ||
6-Month | |||||
%Chg | -9.41% since 06/24/24 | -14.06% since 06/24/24 | -32.84% since 06/24/24 | ||
Low | 83.3100 on 12/20/24 | 377.85 on 12/19/24 | 693.00 on 12/19/24 | ||
High | 109.0000 on 08/28/24 | 519.88 on 11/08/24 | 1,211.20 on 08/27/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 85,946,656 | 105,118,176 | 78,513,104 | ||
Shares Outstanding, K | 968,413 | 257,529 | 109,890 | ||
Annual Sales | 14,800,000,000 | 9,869,200,000 | 13,117,200,000 | ||
Annual Net Income | 2,642,000,000 | 3,619,600,000 | 3,953,600,000 | ||
Last Quarter Sales | N/A | 2,771,900,000 | 3,720,700,000 | ||
Last Quarter Net Income | N/A | 1,045,400,000 | 1,340,600,000 | ||
60-Month Beta | 0.74 | 0.36 | 0.08 | ||
Per-Share Information | |||||
Most Recent Earnings | N/A | 4.38 on 11/04/24 | 12.46 on 10/31/24 | ||
Latest Earnings Date | 08/12/24 | 02/03/25 | 02/07/25 | ||
Most Recent Dividend | 0.675 on 09/10/24 | N/A | N/A | ||
Next Ex-Dividends Date | 09/10/24 | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 17.89 |